Sort
17,054 grants matching “genome editing”
Project 3 Topological mapping of chromatin architectures for hormone-independent gene transcription
$357,000Victor Jin · University Of Texas Hlth Science Center · U54 · FY2020 · CA
Forward and Reverse Genetic Studies of AIS and Spine Development in Zebrafish
$356,970Lilianna Solnica-Krezel · Ut Southwestern Medical Center · P01 · FY2022 · HD
Tissue Damage-Driven Squamous Cell Carcinoma
$356,850Andrew South · Thomas Jefferson University · R01 · FY2021 · CA
Molecular Dissection of an Arntl2 induced pro-metastatic secretome
$356,780Monte Meier Winslow · Stanford University · R01 · FY2019 · CA
Somatic Mutation in the Etiology of Multiple Sclerosis
$356,730Richard H Scheuermann · J. Craig Venter Institute, Inc. · R21 · FY2016 · AI
Molecular mechanisms underlying cortical interneuron synaptic specificity
$356,640Hiroki Taniguchi · Ohio State University · R01 · FY2022 · NS
Therapeutic pathway reprogramming for metabolic liver disease
$356,625Karl-Dimiter Bissig · Baylor College Of Medicine · R01 · FY2018 · DK
The role of Spry2 in beta cell function and the unfolded protein response
$356,625Gregory Michael Ku · University Of California, San Francisco · R01 · FY2018 · DK
The role of Spry2 in beta cell function and the unfolded protein response
$356,625Gregory Michael Ku · University Of California, San Francisco · R01 · FY2020 · DK
The role of Spry2 in beta cell function and the unfolded protein response
$356,625Gregory Michael Ku · University Of California, San Francisco · R01 · FY2016 · DK
The role of Spry2 in beta cell function and the unfolded protein response
$356,625Gregory Michael Ku · University Of California, San Francisco · R01 · FY2017 · DK
The role of Spry2 in beta cell function and the unfolded protein response
$356,625Gregory Michael Ku · University Of California, San Francisco · R01 · FY2019 · DK
Development of a CRISPR-Cas13 Gene Therapy for SOD1-Linked ALS
$356,539Thomas Gaj · University Of Illinois At Urbana-Champaign · R01 · FY2024 · NS
Functional role of dual neurotransmission in aggression
$356,521Ronald Steven Stowers · Montana State University - Bozeman · R01 · FY2023 · GM
Testing the Therapeutic Potential of iPS Cells for Inherited Skin Diseases
$356,513Dennis Roop · University Of Colorado Denver · R01 · FY2012 · AR
Biology and Biotechnology of Cell and Gene Therapy
$356,503David V Schaffer · University Of California Berkeley · T32 · FY2021 · GM
Molecular Mechanisms of Axenfeld-Rieger Syndrome
$356,250Elena V Semina · Medical College Of Wisconsin · R01 · FY2013 · EY
Development and Application of New Genome Editing Tools for the Functional Investigation of Genetic Variants of Uncertain Significance
$356,242Alexis C. Komor · University Of California, San Diego · R35 · FY2023 · GM
Development and Application of New Genome Editing Tools for the Functional Investigation of Genetic Variants of Uncertain Significance
$356,242Alexis C. Komor · University Of California, San Diego · R35 · FY2024 · GM
Development and Application of New Genome Editing Tools for the Functional Investigation of Genetic Variants of Uncertain Significance
$356,242Alexis C. Komor · University Of California, San Diego · R35 · FY2022 · GM
Hepatic Aryl Hydrocarbon Receptor Regulation of Obesity: Mechanisms of Action
$356,219Cornelis Johan Elferink · University Of Texas Med Br Galveston · R01 · FY2023 · ES
Hepatic Aryl Hydrocarbon Receptor Regulation of Obesity: Mechanisms of Action
$356,219Casey W Wright · University Of Texas Med Br Galveston · R01 · FY2024 · ES
Hepatic Aryl Hydrocarbon Receptor Regulation of Obesity: Mechanisms of Action
$356,219Cornelis Johan Elferink · University Of Texas Med Br Galveston · R01 · FY2022 · ES
Hepatic Aryl Hydrocarbon Receptor Regulation of Obesity: Mechanisms of Action
$356,219Casey W Wright · University Of Texas Med Br Galveston · R01 · FY2025 · ES
Project 3: Targeted therapy for splicing factor mutant myeloid malignancies
$356,195Matthew J Walter · Washington University · P50 · FY2025 · CA